65,437 trials
Pain Management
Primary: Average Change in Pain as Measured by the Visual Analog Scale (VAS) — 1.38; 0.93 score on a scale
Major Depressive Disorder
Primary: Change in Cognitive Control Circuit Function Z-score — 0.350; 0.441; 0.105; 0.324 Z-score — p=0.020
Chronic Low Back Pain
Primary: Oswestry Disability Index (ODI) Change — -0.4; 2.7; -0.8; 1.2 units on a scale
Heart Failure With Preserved Ejection Fraction
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 23 Participants
Obstructive Sleep Apnea
Primary: Time to Discharge From Operating Room — 13.0; 13.5 Minutes
Diabetes Mellitus, Type 2
Primary: Usability — 75.0 score on a scale — p=0.02
Recurrent Head and Neck Cancer
Primary: Safety Measures (Adverse Events and Laboratory Parameters) With Repeat Cycles of Treatment. — 5; 0; 8; 8 Participants
Bereavement · Severe Grief Reaction
Primary: The Inventory for Complicated Grief-revised (ICG-r) Score at 6 Months Post-death — 35; 86 Participants
Delayed Ejaculation
Primary: International Index of Erectile Function (IIEF) Scale Score — 7.5; 9.7 score on a scale
Glaucoma
Primary: Physician Follow up — 150; 144; 97; 99 Participants — p=0.7399
Hearing Loss
Primary: Abbreviated Profile of Hearing Aid Benefit (APHAB) — 30.1; 21.4 score on a scale (1-99)
Heart Failure · Cardiovascular Disease · Ventricular Dysfunction
Primary: Survival — 293 Participants
Acute Myeloid Leukemia · Acute Myeloid Leukemia in Remission · Aplastic Anemia
Primary: Overall Survival (OS) — 74 percentage of participants
Trypanosomiasis, African · Trypanosoma Brucei Gambiense; Infection · Sleeping Sickness
Primary: Occurrence of Any TEAEs — 195; 69 Participants
Urinary Incontinence, Stress · Urinary Incontinence, Urge
Primary: UDI-LF Total Score Change From Baseline — -82.2; -84.6; -74.9; -89.1 units on a scale